Panacea Index Logo

Command Palette

Search for a command to run...

Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
January 1, 2012
Soundravally Rajendiran et al. (3 authors)
Journal ArticleRandomized Controlled TrialHuman StudyClinical
Study Details

Study Goal

The researchers aimed to evaluate the effects of iron supplementation and anti-H. pylori therapy on oxidative stress markers and anemia correction in H. pylori-infected patients.

Results Summary

Iron supplementation combined with anti-H. pylori therapy significantly reduced oxidative stress markers (protein carbonyls) and improved antioxidant status, iron, hemoglobin, and ferritin levels, whereas iron supplementation alone did not produce significant changes.

Population

Twenty anemic H. pylori-infected patients and fifteen healthy controls.

Effective Dosage

Not specified

Duration

1 month

Interactions

None mentioned

Extracted Claims (15)
InterventionDirectionEndpointPopulationDosageImpactClaim #
-
increase
protein carbonyls (PCOs)
anemic H. pylori-infected patients
-
significantly increased
#1
-
decrease
total antioxidant status
anemic H. pylori-infected patients
-
significantly decreased
#2
-
decrease
iron levels
anemic H. pylori-infected patients
-
significantly decreased
#3
-
decrease
hemoglobin levels
anemic H. pylori-infected patients
-
significantly decreased
#4
-
decrease
ferritin levels
anemic H. pylori-infected patients
-
significantly decreased
#5
iron supplementation and anti-H pylori therapy
decrease
PCOs level
Group I patients (anemic H. pylori-infected)
-
decreased significantly
#6
iron supplementation and anti-H pylori therapy
increase
total antioxidant status
Group I patients (anemic H. pylori-infected)
-
significant increase
#7
iron supplementation and anti-H pylori therapy
increase
iron levels
Group I patients (anemic H. pylori-infected)
-
significant increase
#8
iron supplementation and anti-H pylori therapy
increase
hemoglobin levels
Group I patients (anemic H. pylori-infected)
-
significant increase
#9
iron supplementation and anti-H pylori therapy
increase
ferritin levels
Group I patients (anemic H. pylori-infected)
-
significant increase
#10
iron supplementation
no change
PCOs levels
Group II patients (anemic H. pylori-infected)
no significant change
No significant alterations
#11
iron supplementation
no change
total antioxidant status
Group II patients (anemic H. pylori-infected)
no significant change
No significant alterations
#12
iron supplementation
no change
iron levels
Group II patients (anemic H. pylori-infected)
no significant change
No significant alterations
#13
iron supplementation
no change
hemoglobin levels
Group II patients (anemic H. pylori-infected)
no significant change
No significant alterations
#14
iron supplementation
no change
ferritin levels
Group II patients (anemic H. pylori-infected)
no significant change
No significant alterations
#15
Abstract

BACKGROUND/AIM: Collective evidences suggest the causal association of Helicobacter pylori infection with iron deficiency anemia. Generation of free radicals against this bacterium can lead to turbulence in oxidative-antioxidative system. This study was undertaken to evaluate the marker of oxidative protein injury, protein carbonylation, and total antioxidant status in anemic H. pylori-infected patients and to observe the alteration in them after treatment for 1 month with oral ferrous sulfate and anti-H. pylori therapy. Twenty anemic H. pylori-infected patients were randomly divided into 2 groups. The H. pylori-infected patients in Group I received both iron supplementation and anti-H pylori therapy, whereas patients in Group II received only the iron supplementation. Fifteen healthy volunteers served as controls. All the study parameters were estimated after 1 month of the treatment. MATERIALS AND METHODS: Protein carbonylation and total antioxidant status were estimated using colorimetric method. Hematologic parameters were evaluated using Sysmex-K-100 automated cell counter. RESULTS: In anemic H. pylori-infected patients, the protein carbonyls (PCOs) were significantly increased, whereas the total antioxidant status, iron, hemoglobin, and ferritin levels were significantly decreased compared with the controls. In Group I, while the PCOs level decreased significantly, there was a significant increase in the total antioxidant status, iron, hemoglobin, and ferritin levels after 1 month. No significant alterations were noted in the levels of PCOs, total antioxidant status, iron, hemoglobin, or ferritin in Group II patients after 1 month of the treatment. CONCLUSIONS: The findings from this study indicate that treatment for both anemia and H. pylori infections is required for lowering the oxidative stress markers, which synergistically bring about an appropriate correction of anemia soon in these patients.

Medical Subject Headings (MeSH)
2-PyridinylmethylsulfinylbenzimidazolesAdministration, OralAdultAnemia, Iron-DeficiencyAnti-Infective AgentsClarithromycinDietary SupplementsDrug Administration ScheduleFemaleFerrous CompoundsHelicobacter InfectionsHelicobacter pyloriHumansLansoprazoleMaleMiddle AgedProtein CarbonylationTinidazole
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations5
Citations/Year0.4
Relative Citation Ratio0.18
NIH Percentile9.2%
Research Impact Scores
APT Score0.05
Weight Score1.24
Normalized Score0.69
Related Supplements